What is triage
triage definition categories emergency medicine
| Color | Priority | Meaning |
|---|---|---|
| 🔴 Red | 1st - Immediate | Life-threatening shock or hypoxia is present or imminent, but the patient can likely be stabilized and will probably survive with immediate care |
| 🟡 Yellow | 2nd - Urgent | Injuries have systemic implications but not yet life-threatening; patient can safely wait 45-60 minutes |
| 🟢 Green | 3rd - Non-urgent | Localized injuries with no immediate systemic implications; unlikely to deteriorate for hours (the "walking wounded") |
| ⚫ Black | Dead/Expectant | No spontaneous breathing or circulation; or catastrophically injured with minimal chance of survival regardless of care. Goal is comfort/pain control |
| ESI Level | Criteria |
|---|---|
| 1 | Requires Immediate Life-Saving Intervention |
| 2 | High Risk Situation; Lethargic; Severe Distress; Dangerous Vital Signs |
| 3 | Multiple Resources Required, but Stable Vitals |
| 4 | One Required Resource |
| 5 | No Required Resources |
What is hematuria
hematuria causes evaluation treatment clinical overview
A urine dipstick alone is NOT sufficient. Microscopic analysis of a clean midstream urine sample is required to confirm true hematuria - Campbell Walsh Wein Urology.
| Category | Causes |
|---|---|
| Infections | UTI (cystitis, pyelonephritis), prostatitis, sexually transmitted infections |
| Stones | Kidney, ureter, or bladder calculi (cause traumatic bleeding and irritation) |
| Malignancy | Bladder cancer (most common cause in >50 yr), renal cell carcinoma, prostate cancer, urothelial cancer |
| Glomerular/Renal | IgA nephropathy, thin basement membrane disease, membranous nephropathy, focal glomerulosclerosis |
| Trauma | Injury to kidney, ureter, bladder, or urethra |
| Benign Prostatic Hyperplasia (BPH) | Enlarged prostate causing bladder neck irritation |
| Coagulation disorders | Anticoagulant use (heparin, warfarin, aspirin), bleeding disorders |
| Drugs | Cyclophosphamide (hemorrhagic cystitis), penicillins, sulfonamides, NSAIDs |
| Exercise-induced | Strenuous exercise (especially long-distance running) - bleeding from bladder mucosa |
| Inherited disorders | Sickle cell disease, Alport syndrome, G6PD deficiency |
| Pattern | Likely Source |
|---|---|
| Initial stream (only at start) | Urethra or prostate |
| Terminal (only at end) | Bladder neck |
| Total/Throughout stream | Bladder, ureter, or kidney |
| Cause | Treatment |
|---|---|
| UTI | Antibiotics |
| Kidney/bladder stones | Urologic intervention (ESWL, ureteroscopy, etc.) |
| Bladder cancer | Depends on staging: surveillance, TURBT, immunotherapy (BCG), radical cystectomy, chemotherapy |
| Glomerulonephritis | Immunosuppression, RAAS blockade, nephrology referral |
| BPH | Alpha-blockers, 5-alpha-reductase inhibitors (finasteride, dutasteride) |
| Exercise-induced | Modify exercise; no specific treatment needed |
| Drug-induced | Stop offending medication |
Vap full form
Name one sockable rhythm and non sockable rhythm
| Shockable | Non-Shockable | |
|---|---|---|
| Rhythms | VF, Pulseless VT | Asystole, PEA |
| Treatment | Defibrillate + CPR | CPR + Epinephrine only |
The logic: defibrillation works by stopping chaotic electrical activity so the heart's natural pacemaker can restart. In asystole, there is no activity to stop - shocking it does nothing.
Pressure ulcer
pressure ulcer stages classification prevention treatment nursing
| Stage | Description |
|---|---|
| Stage 1 | Intact skin with non-blanchable redness. No open wound. May appear purple/blue on dark skin. Reversible if treated immediately. |
| Stage 2 | Partial thickness skin loss - dermis exposed. May appear as a shallow open ulcer (red/pink) or intact/ruptured blister. No subcutaneous fat visible. |
| Stage 3 | Full thickness skin loss. Subcutaneous fat may be visible. Wound edges may be rolled (epibole). Bone, tendon, muscle NOT visible. |
| Stage 4 | Full thickness tissue loss exposing bone, tendon, or muscle. High risk of osteomyelitis. |
| Unstageable | Full thickness ulcer covered by slough (yellow/tan) or eschar (black/brown) - depth cannot be assessed until debrided. |
| Deep Tissue Injury (DTI) | Intact or non-intact skin with purple/maroon discoloration or blood-filled blister from damage to underlying soft tissue from pressure/shear. |
A formal risk assessment using the Braden Scale should be done for all at-risk patients (assesses sensory perception, moisture, activity, mobility, nutrition, friction/shear).
| Aspect | Approach |
|---|---|
| Systemic | Vitamin C (84% reduction in ulcer surface area); antibiotics (clindamycin + gentamicin for infected ulcers); air-fluidized bed therapy |
| Wound cleaning | Normal saline (agent of choice); avoid povidone-iodine, hydrogen peroxide, hypochlorite |
| Debridement | Wet-to-dry dressings with saline; enzymatic agents; surgical debridement for necrotic tissue |
| Dressings | Stage 2: occlusive/hydrocolloid dressings; Stage 3/4: saline-soaked gauze |
| Moist wound environment | Maintained once granulation/epithelialization begins |
| Surgical | Used when necrotic tissue cannot be removed otherwise (to prevent septicemia) |
Define CAUTI
CAUTI catheter associated urinary tract infection definition criteria prevention CDC
"CAUTIs are the most common nosocomial (hospital-acquired) infection." - Sabiston Textbook of Surgery
| In patients without a catheter (recently removed) | In patients with a catheter |
|---|---|
| Dysuria, urgency, frequency | Fever, rigors, malaise |
| Suprapubic pain | Altered mental status |
| Flank pain / CVA tenderness | Flank or pelvic discomfort |
| Hematuria | Acute hematuria |
Note: Dysuria and frequency are NOT reliable symptoms in patients with an indwelling catheter, as the catheter itself can cause these symptoms.
| Stage | Action |
|---|---|
| Stage 0 | Avoid Foley catheter placement entirely if not needed - "No Foley = No CAUTI" |
| Stage 1 | If needed, insert using strict aseptic technique |
| Stage 2 | Maintain awareness and proper care of catheters in use (closed drainage system, keep below bladder level) |
| Stage 3 | Remove promptly when no longer medically necessary |
Name the oxygen device with their flow rate
| Device | Flow Rate | FiO2 Delivered |
|---|---|---|
| Nasal Cannula | 1-6 L/min | 24% - 44% |
| Simple Face Mask | 5-10 L/min | 35% - 55% |
| Partial Rebreather Mask | 6-10 L/min | 40% - 70% |
| Non-Rebreather Mask (NRM) | 10-15 L/min | 60% - 95% |
Rule of thumb for nasal cannula: each 1 L/min increase adds ~4% FiO2
- 1 L/min = 24%, 2 L/min = 28%, 3 L/min = 32%, 4 L/min = 36%, 5 L/min = 40%, 6 L/min = 44%
| Device | Flow Rate | FiO2 Delivered |
|---|---|---|
| Venturi Mask | 2-15 L/min (set by color-coded valve) | 24%, 28%, 31%, 35%, 40%, 60% (precise) |
| High-Flow Nasal Cannula (HFNC) | Up to 60 L/min | 21% - 100% (titrated) |
| Device | Flow Rate | FiO2 Delivered |
|---|---|---|
| Tracheostomy Mask/Collar | 8-10 L/min | ~35% - 60% |
| Aerosol/Nebulizer Mask | 8-10 L/min | ~35% - 60% |
| Bag-Valve Mask (BVM) with O2 | 15 L/min | ~100% (with reservoir) |
| Mechanical Ventilator | Variable | 21% - 100% (fully controlled) |
| CPAP / BiPAP | Variable | 21% - 100% |
| Device | Key Feature |
|---|---|
| Nasal Cannula | Most comfortable, used for mild hypoxia; minimum 5 L/min for face mask to flush CO2 |
| Simple Face Mask | Must use ≥5 L/min to prevent CO2 rebreathing |
| Non-Rebreather | Emergency high-flow O2; one-way valve prevents exhaled air re-entry |
| Venturi Mask | Best for COPD patients - delivers precise, controlled FiO2 |
| HFNC | Provides PEEP effect, humidified O2, used in respiratory failure |
| BVM | Used during CPR or apnea; requires good mask seal |
In COPD patients, use a Venturi mask to avoid giving too much oxygen, which can suppress their hypoxic drive and cause CO2 retention.
Vital sing or normal range
| Vital Sign | Normal Range |
|---|---|
| Temperature | 36.1°C - 37.2°C (97°F - 99°F) |
| Heart Rate (Pulse) | 60 - 100 beats/min |
| Respiratory Rate | 12 - 20 breaths/min |
| Blood Pressure | Systolic: 90-120 mmHg / Diastolic: 60-80 mmHg |
| Oxygen Saturation (SpO2) | 95% - 100% |
| Blood Glucose (fasting) | 70 - 100 mg/dL |
| Pain Score | 0 (considered the 6th vital sign) |
| Age Group | Heart Rate (bpm) | Respiratory Rate (breaths/min) | BP Systolic (mmHg) |
|---|---|---|---|
| Newborn (0-1 month) | 100 - 160 | 30 - 60 | 60 - 90 |
| Infant (1-12 months) | 100 - 160 | 30 - 60 | 70 - 100 |
| Toddler (1-3 years) | 90 - 150 | 24 - 40 | 80 - 110 |
| Preschool (3-5 years) | 80 - 140 | 22 - 34 | 80 - 110 |
| School Age (6-12 years) | 70 - 120 | 18 - 30 | 90 - 120 |
| Adolescent (12-18 years) | 60 - 100 | 12 - 20 | 100 - 130 |
| Category | Temperature |
|---|---|
| Hypothermia | <35°C (<95°F) |
| Normal | 36.1°C - 37.2°C |
| Low-grade fever | 37.3°C - 38°C |
| Fever (Pyrexia) | >38°C (>100.4°F) |
| Hyperpyrexia | >41°C (>105.8°F) |
| Category | Systolic | Diastolic | |
|---|---|---|---|
| Normal | <120 | and | <80 |
| Elevated | 120-129 | and | <80 |
| Stage 1 HTN | 130-139 | or | 80-89 |
| Stage 2 HTN | ≥140 | or | ≥90 |
| Hypertensive Crisis | >180 | and/or | >120 |
| Hypotension | <90 systolic |
| Term | Rate |
|---|---|
| Bradycardia | <60 bpm |
| Normal | 60 - 100 bpm |
| Tachycardia | >100 bpm |
| Term | Rate |
|---|---|
| Bradypnea | <12 breaths/min |
| Normal | 12 - 20 breaths/min |
| Tachypnea | >20 breaths/min |
| Apnea | Absence of breathing |
| Category | SpO2 |
|---|---|
| Normal | 95% - 100% |
| Acceptable (COPD) | 88% - 92% |
| Mild hypoxia | 91% - 94% |
| Moderate hypoxia | 86% - 90% |
| Severe hypoxia | <85% |
"60-100-12-20-120/80-37-95"
- HR: 60-100 | RR: 12-20 | BP: 120/80 | Temp: 37°C | SpO2: ≥95%